Alerts will be sent to your verified email
Verify EmailWANBURY
Wanbury
|
Shivalik Rasayan
|
Kwality Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-30.56 % | 7.33 % | 25.87 % |
5yr average Equity Multiplier
|
-3.1 | 1.84 | 2.2 |
5yr Average Asset Turnover Ratio
|
1.51 | 0.47 | 1.09 |
5yr Avg Net Profit Margin
|
7.58 % | 8.37 % | 10.7 % |
Price to Book
|
15.93 | 1.82 | 3.71 |
P/E
|
30.93 | 56.77 | 24.61 |
5yr Avg Cash Conversion Cycle
|
-119.82 Days | 79.22 Days | 46.51 Days |
Inventory Days
|
20.62 Days | 63.09 Days | 59.9 Days |
Days Receivable
|
49.78 Days | 114.67 Days | 110.56 Days |
Days Payable
|
205.91 Days | 157.87 Days | 112.27 Days |
5yr Average Interest Coverage Ratio
|
2.36 | 10.93 | 15.91 |
5yr Avg ROCE
|
-51.74 % | 9.58 % | 34.24 % |
5yr Avg Operating Profit Margin
|
4.22 % | 18.09 % | 20.92 % |
5 yr average Debt to Equity
|
-0.61 | 0.16 | 0.52 |
5yr CAGR Net Profit
|
-2.79 % | -1.91 % | 23.39 % |
5yr Average Return on Assets
|
11.1 % | 3.97 % | 12.43 % |
Shareholdings
|
|||
Promoter Holding
|
39.76 % | 47.37 % | 54.83 % |
Share Pledged by Promoters
|
76.74 % | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-0.13 % | -2.95 % | 0.4 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Wanbury
|
Shivalik Rasayan
|
Kwality Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Segment Break-Up
|
Segment Break-Up
|
-
|
Segment Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|